| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA5040786 | F | Antiproliferative activity against human KMS-11 cells assessed as reduction in cell viability incubated for 14 days by LTP assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 2. | ALA5040787 | B | Inhibition of SETD2 (unknown origin) preincubated for 30 mins followed by SAM substrate addition measured after 2 hrs by plate reader method | Homo sapiens | 30 | single protein format | Scientific Literature | ||
| 3. | ALA5040789 | B | Inhibition of SETD2 in human A549 cells assessed as H3K36 trimethyl mark incubated for 3 days by in-cell western assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
| 4. | ALA5040790 | A | Stability in mouse hepatocytes assessed as intrinsic clearance measured upto 60 minutes by LC/MS/MS analysis | Mus musculus | 9 | cell-based format | Scientific Literature | ||
| 5. | ALA5040791 | A | Stability in human hepatocytes assessed as intrinsic clearance measured upto 120 minutes by LC/MS/MS analysis | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 6. | ALA5040792 | A | Apparent permeability across apical to basal membrane in human Caco-2 cells measured after 2 hrs by LC-MS/MS analysis | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 7. | ALA5040793 | A | Efflux ratio of apparent permeability across basolateral to apical membrane over apical to basolateral membrane in human Caco-2 cells after 2 hrs by LC-MS/MS analysis | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 8. | ALA5040794 | A | Inhibition of CYP2C19 in human liver microsomes using (s)-Mephenytoin as substrate by LC-MS/MS analysis | Homo sapiens | 1 | microsome format | Scientific Literature | ||
| 9. | ALA5040795 | A | Inhibition of CYP1A2 in human liver microsomes using Phenacetin as substrate by LC-MS/MS analysis | Homo sapiens | 1 | microsome format | Scientific Literature | ||
| 10. | ALA5040796 | A | Inhibition of CYP2B6 in human liver microsomes using Bupropion as substrate by LC-MS/MS analysis | Homo sapiens | 1 | microsome format | Scientific Literature | ||
| 11. | ALA5040797 | A | Inhibition of CYP2C8 in human liver microsomes using Paclitaxel as substrate by LC-MS/MS analysis | Homo sapiens | 1 | microsome format | Scientific Literature | ||
| 12. | ALA5040798 | A | Inhibition of CYP2C9 in human liver microsomes using Tolbutamide as substrate by LC-MS/MS analysis | Homo sapiens | 1 | microsome format | Scientific Literature | ||
| 13. | ALA5040799 | A | Inhibition of CYP2D6 in human liver microsomes using Dextromethorphan as substrate by LC-MS/MS analysis | Homo sapiens | 1 | microsome format | Scientific Literature | ||
| 14. | ALA5040800 | A | Inhibition of CYP3A4 in human liver microsomes using Midazolam as substrate by LC-MS/MS analysis | Homo sapiens | 1 | microsome format | Scientific Literature | ||
| 15. | ALA5040801 | T | Inhibition of hERG (unknown origin) | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 16. | ALA5040802 | A | Clearance in CD-1 mouse at 1 mg/kg, iv by LC-MS/MS analysis | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 17. | ALA5040803 | A | Volume of distribution in CD-1 mouse at 1 mg/kg, iv by LC-MS/MS analysis | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 18. | ALA5040804 | A | Terminal half life in CD-1 mouse at 1 mg/kg, iv by LC-MS/MS analysis | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 19. | ALA5040806 | F | Antiproliferative activity against human KMS-34 cells assessed as reduction in cell viability incubated for 14 days by LTP assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 20. | ALA5040807 | A | Oral fraction absorbed in CD-1 mouse at 30 mg/kg by LC-MS/MS analysis | Mus musculus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!